Professor Dion Morton recently spoke with Dr Nicolas Avellaneda about the FOxTROT Study. Watch this video to find out more about the trial, and how this trial could change the way we are treating patients with colon cancer.
ESCP's Global Reach Committee, with leading speakers and panelists, will explore the updated management for fecal incontinence from a global perspective and discuss the challenges and opportunities for improving patient outcomes worldwide. Join us.
March’s paper of the month looks at the FOxTROT trial, a randomised control trial comparing recurrence rate in patients with locally advanced colon cancer receiving neoadjuvant chemotherapy (NAC) vs. postoperative chemotherapy.